Luckianow joins Greenwood Group
BUFFALO, N.Y. The Greenwood Group on Wednesday announced the addition of Neil Luckianow to its team.
“[Luckianow’s] expertise in trade marketing and sales will be a great asset to our organization and our clients. We’re excited to have him on board,” stated Patrick O’Leary, president of Greenwood Group.
Luckianow has 25 years of experience and is a recognized expert in trade marketing, trade relations and sales management. His achievements include designing retail sales and marketing strategies that reverse market-share slides and help clients bring products successfully from inception to full commercialization, the Greenwood Group stated.
FDA approves Dr. Reddy’s heartburn generic
HYDERABAD, India The Food and Drug Administration has approved a generic version of the OTC formulation of AstraZeneca’s Prilosec.
Indian generic drug maker Dr. Reddy’s Labs announced Tuesday the approval of its omeprazole magnesium in the 20.6 mg strength, which is used to treat heartburn.
The company said it expects to begin shipment of the drug in second quarter of its fiscal year 2010.
Schering-Plough moves forward on Zegerid switch, responds to FDA complete response letter
SAN DIEGO There is still an opportunity for a second proton-pump inhibitor to join Novartis Consumer Healthcare’s Prevacid 24HR this fall.
Santarus on Tuesday announced that Schering-Plough HealthCare Products has submitted its response to the Food and Drug Administration’s complete response letter issued in January.
Schering-Plough had licensed the OTC switch rights from Santarus for Zegerid, an omeprazole/sodium bicarbonate combination product, in 2006.